CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Pharco Pharmaceuticals is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Pharco Pharmaceuticals
Alexandria-Cairo Desert Rd. Km 31 Amriya
Phone: +20 34480130p:+20 34480130 ALEXANDRIA, 21311  Egypt Ticker: PHPCPHPC
Business Summary
Pharco Pharmaceuticals, also known as Islamic Company for Pharmaceuticals, Chemicals and Medical Appliances, is an Egypt-based company, whose main activities include development, manufacturing, marketing and distribution of pharmaceutical products. Its product range includes alimentary, cardiovascular, central nervous system, dermatological, other miscellaneous preparations and products under license. The Company's divisions ranges from quality assurance and quality control to information technology, export, sales and marketing and human resources. Pharco Pharmaceuticals operates three plants: a non-penicillin plant, a cephalosporin plant and a penicillin plant. The Company's subsidiaries are Pharco Pharmaceuticals, Amriya Pharmaceutical Industries, European Egyptian Pharmaceutical Industries, Safe Pharma, Technopharma Egypt, Pharco B International, Pharco Impex, Pharco Trading and Abu Kir Trading.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/200912/31/2008Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Chairman, Director Sherine H.Helmy 12/1/2022 6/7/2022
President, Founder Hasan A.Helmy
Chief Financial Officer MohammedDesouky
3 additional Officers and Directors records available in full report.

Business Names
Business Name
Abu Kir Trading
Amriya Pharmaceutical Industries
European Egyptian Pharmaceutical Industries
7 additional Business Names available in full report.

General Information
Number of Employees: 1,665 (As of 12/31/2006)
Outstanding Shares: 100,000,000 (As of 9/30/2009)
Stock Exchange: CAI
Fax Number: +20 34480130


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, August 29, 2023